Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma
Links shared publicly online about this topic.
- 429total visits
Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma
Polaris Group announced today the enrollment of the first patient in a Phase 2 clinical trial of ADI-PEG 20, the company's novel enzyme-based treatment for malignant mesothelioma.
View full resource at news-medical.net
Tags: Cancer, Lung Cancer, Lung, Phase 2 Clinical Trial, Clinical Trial, News
Most Recently Shared on March 19, 2011 at 7:05 am By:
Prostate Cancer: Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma: Polaris Gro... http://bit.ly/hAbSUQ
Also Shared By:
Polaris Enrolls First Patient In Phase 2 Clinical Trial Of ADI-PEG 20 For The Treatment Of Malignant Mesothelioma
medicalnewstoday.com — “Polaris Group announced the enrollment of the first patient in a Phase 2 clinical trial of ADI-PEG 20 (pegylated arginine deiminase), the company's novel enzyme-based treatment for malignant mesot” View full resource at medicalnewstoday.com
Most Recently Shared on March 20, 2011 at 9:05 am By:
Polaris Enrolls First Patient In Phase 2 Clinical Trial Of ADI-PEG 20 For The Treatment Of Malignant Mesothelioma http://mnt.to/3Svp #cancer
Advertisement
News-Medical.Net
@Lung_Cancer_
Lung Cancer News: Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma: Polaris Gr... http://bit.ly/hAbSUQ
1 year ago...